Return to search

THE ROLE OF FEMALE SEX HORMONES AND LACTOBACILLI ON GENITAL EPITHELIAL CELL BARRIER FUNCTIONS AND INNATE IMMUNE RESPONSES IN THE PRESENCE AND ABSENCE OF HIV

Background: Approximately 40% of global human immunodeficiency virus-1 (HIV) transmission occurs in the female genital tract (FGT). Epithelial cells lining the FGT comprise the first barrier to HIV-1 entry. The functions of these cells are influenced by female sex hormones and the mucosal microbiota. Studies have suggested that hormonal environment and a dysbiosis of the FGT microbiota may lead to inflammation in the genital mucosa and enhance HIV acquisition. A Lactobacillus dominant microenvironment in the FGT is considered to have protective functions against sexually transmitted pathogens, however the interaction between sex hormones and lactobacilli and their effect on epithelial cell functions remains to be determined.
Methods of Study: For these studies, primary genital epithelial cells (GECs) were isolated from hysterectomy tissues obtained following patient consent. GEC cultures were grown to confluence on cell culture inserts in the presence or absence of the female sex hormones estrogen (E2), progesterone (P4), or medroxyprogesterone acetate (MPA). Polarized monolayers were exposed to two probiotic strains of Lactobacillus: L. reuteri (RC-14) or L. rhamnosus (GR-1), or the most common strain of bacteria found in the FGT, L. crispatus in the presence or absence of HIV-1. Cell viability, barrier integrity, and innate inflammatory factors were among the primary measures performed.
Results: In our system, cell viability was unaltered in the presence of Lactobacillus species and/or female sex hormones. All three strains of bacteria (L. crispatus and probiotic lactobacilli GR-1 and RC-14) significantly increased GEC barrier integrity, as measured by transepithelial electrical resistance (TER). Both GR-1 and RC-14 significantly reduced GEC barrier permeability as measured by a dextran dye leakage assay, whereas L. crispatus did not. Conversely, hormones did not alter barrier integrity nor barrier permeability. However, hormones did alter secretion of cytokines and chemokins by GECs. GECs grown in the presence of estrogen decreased TNF-α, IL-1α, IL-1β and IL-8 secretion in comparison to no hormone treatment, while GECs grown in the presence of MPA significantly decreased MIP-1α and TNF-α secretion. In the presence of HIV both GR-1 and RC-14 were able to confer an increase in barrier integrity similar to that observed with GR-1 and RC-14 treatment alone. Addionally, GECs grown in the presence of E2 and MPA displayed a less inflammatory (TNF-α, IL-1α, and IL-1β) environment when exposed to HIV compared to no hormone and P4. Interstingly, the decrease in inflammation was not observed when measuring chemokines such as IL-8 and RANTES. Furthermore, probiotic bacteria were able to significantly reduce HIV mediated increases in TNF-α when grown in the presence of no hormone, P4, and MPA. A similar trend was observed for GECs grown in the presence of E2 however, given that E2 reduced the TNF-α response mediated by HIV, results were not significant. Overall, probiotic lactobacilii GR-1 and RC-14 enhanced GEC barrier functions while E2 and MPA appeared to exert an anti-inflammatory effect on epithelial cell innate responses in both the presence and absence of HIV.
Conclusions: In our system, probiotic lactobacilli enhanced GEC barrier functions and estrogen appeared to exert an anti-inflammatory effect on epithelial innate responses. Enhanced barrier function and decreased inflammation correlate with decreased in HIV acquisition and replication. These studies provide an insight into how factors in the genital microenvironment can affect HIV acquisition in the FGT, and will subsequently assist in the development of prophylactic strategies to reduce HIV transmission. / Thesis / Master of Science (MSc) / Approximately 40% of global HIV transmission occurs in the female genital tract. Although women make up more than 50% of infected individuals worldwide, the details regarding how HIV infection starts in the female genital tract remains poorly understood. The cells that line the genital tract are the first barrier against HIV entry. These cells are influenced by common factors within the genital tract microenvironment such as female sex hormones and natural bacterial populations. Previous studies have suggested that certain hormonal contraceptives or a build-up of pathogenic bacteria within the genital tract, leads to an inflammatory microenvironment and may enhance HIV acquisition. Comparatively, ‘good bacteria’ within the microenvironment have been shown to have protective effects against sexually transmitted infections. For this study, we were interested in understanding how different hormones (estrogen, progesterone and progesterone based hormonal contraceptives) and ‘good bacteria’ (specifically probiotic strains of lactobacilli), affect the cells that line the genital tract and local inflammation in the presence and absence of HIV. Therefore, we obtained cells that line the genital tract (epithelial cells) from women undergoing hysterectomies. The cells were grown in the presence or absence of hormones, exposed to ‘good bacteria’ and then challenged with HIV. In our system, probiotic lactobacilli enhanced genital epithelial cell barrier functions and estrogen appeared to exert an anti-inflammatory effect on epithelial cells. Furthermore, when genital epithelial cells were pre-treated with lactobacilli and exposed to HIV, lactobacilli treatment was able to protect against HIV mediated barrier disruption. Lactobacilli treated genital epithelial cells also reduced inflammatory markers in the presence HIV. Enhanced barrier function and decreased inflammation correlate with decrease in HIV infection and replication. This study provides insight into how factors in the genital microenvironment can affect HIV infection in the female genital tract and suggests potential prophylactic strategies to reduce HIV infection.

Identiferoai:union.ndltd.org:mcmaster.ca/oai:macsphere.mcmaster.ca:11375/21229
Date January 2017
CreatorsDizzell, Sara
ContributorsKaushic, Charu, Medical Sciences (Molecular Virology and Immunology Program)
Source SetsMcMaster University
LanguageEnglish
Detected LanguageEnglish
TypeThesis

Page generated in 0.0019 seconds